← Leaderboards
John Glaspy
University Of California Los Angeles
$2,898,118
Attributed
$2,898,118
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $193.5K · FY2009–25$200K$150K$100K$50K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,898,118 · 7
By mechanism
P30$1,846,787 · 5
U54$636,799 · 1
M01$414,532 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Judith Cheryl Gasson$28,230,504
- Harvey R. Herschman$16,718,124
- Robin Farias-Eisner$1,512,016
- Michael A Teitell$22,516,970
- Kenneth Allan Dorshkind$13,544,292
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsDesignClinical TrialsResearch StudyClinical ResearchResourcesCommunitiesResearch FacilityPeer ReviewOncologyResearch PersonnelCancer Center Support GrantAreaLeadershipDiagnosisPreventionAnticancer ResearchJonsson Comprehensive Cancer Center Of University Of California Los AngelesBasic ScienceHuman SubjectBaseLos AngelesAuthorityCancer Science
Grant awards (19)
Protocol Review and Monitoring System (PRMS)$163,513
P30 · FY2025 · CA · contact PI
Protocol Review and Monitoring System$193,484
P30 · FY2024 · CA · contact PI
Protocol Review and Monitoring System$193,489
P30 · FY2023 · CA · contact PI
Protocol Review and Monitoring System$193,489
P30 · FY2022 · CA · contact PI
Protocol Review and Monitoring System$193,489
P30 · FY2021 · CA · contact PI
Protocol Review and Monitoring System$146,609
P30 · FY2020 · CA · contact PI
Resource for Minority Patient Recruitment$139,554
U54 · FY2013 · CA · contact PI
Resource for Minority Patient Recruitment$148,406
U54 · FY2012 · CA · contact PI
Resource for Minority Patient Recruitment$114,020
U54 · FY2011 · CA · contact PI
Women's Cancers$54,704
P30 · FY2011 · CA · contact PI
Resource for Minority Patient Recruitment$118,225
U54 · FY2010 · CA · contact PI
Women's Cancers$69,664
P30 · FY2010 · CA · contact PI
Resource for Minority Patient Recruitment$116,594
U54 · FY2009 · CA · contact PI
Women's Cancers$66,090
P30 · FY2009 · CA · contact PI
CORE--CLINICAL TRIAL PROTOCOL REVIEW AND MONITORING SYSTEM$167,178
P30 · FY2002 · CA
RANDOMIZED TRIAL OF PERIPHERAL BLOOD PROGENITOR CELL (PBPC) MOBILIZATION$207,266
M01 · FY2001 · RR
RANDOMIZED TRIAL OF PERIPHERAL BLOOD PROGENITOR CELL (PBPC) MOBILIZATION$207,266
M01 · FY2001 · RR
CORE--CLINICAL TRIAL PROTOCOL REVIEW AND MONITORING SYSTEM$167,178
P30 · FY2001 · CA
CORE--CLINICAL TRIAL PROTOCOL REVIEW AND MONITORING SYSTEM$237,900
P30 · FY2000 · CA